JP Morgan Chase’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,318
| Closed | -$13.3K | – | 8096 |
|
|
2023
Q3 | $13.3K | Sell |
13,318
-133,096
| -91% | -$102K | ﹤0.01% | 6180 |
|
|
2023
Q2 | $71.7K | Sell |
146,414
-1,127,122
| -89% | -$922K | ﹤0.01% | 5613 |
|
|
2023
Q1 | $1.48M | Sell |
1,273,536
-118,259
| -8% | -$216K | ﹤0.01% | 3761 |
|
|
2022
Q4 | $3.73M | Sell |
1,391,795
-226,274
| -14% | -$596K | ﹤0.01% | 3067 |
|
|
2022
Q3 | $4.63M | Buy |
1,618,069
+244,089
| +18% | +$1.04M | ﹤0.01% | 2815 |
|
|
2022
Q2 | $6.83M | Buy |
1,373,980
+238,061
| +21% | +$1.25M | ﹤0.01% | 2492 |
|
|
2022
Q1 | $8.08M | Sell |
1,135,919
-599,111
| -35% | -$4.96M | ﹤0.01% | 2589 |
|
|
2021
Q4 | $31.5M | Buy |
1,735,030
+306,859
| +21% | +$6.62M | ﹤0.01% | 1468 |
|
|
2021
Q3 | $27.9M | Buy |
1,428,171
+150,294
| +12% | +$5.72M | ﹤0.01% | 1521 |
|
|
2021
Q2 | $57.3M | Sell |
1,277,877
-59,924
| -4% | -$2.78M | 0.01% | 1154 |
|
|
2021
Q1 | $67.2M | Buy |
1,337,801
+676,901
| +102% | +$46.2M | 0.01% | 1040 |
|
|
2020
Q4 | $59.1M | Buy |
660,900
+19,391
| +3% | +$1.63M | 0.01% | 1006 |
|
|
2020
Q3 | $47.7M | Buy |
+641,509
| New | +$40.7M | 0.01% | 998 |
|
JP Morgan Chase's CELL Position: Q4 2023 in Review
JP Morgan Chase sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 13,318 shares — an estimated $13.3K sold.
JP Morgan Chase first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $67.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.
- JP Morgan Chase reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- JP Morgan Chase sold 13,318 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $13.3K.
- JP Morgan Chase first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
- JP Morgan Chase's PhenomeX Inc. Common Stock position peaked at $67.2M in Q1 2021.
- 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.